KBC Group NV Boosts Holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR)
KBC Group NV boosted its position in Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 53.8% during the 4th quarter, HoldingsChannel.com reports. The firm owned 2,151 shares of the company’s stock after purchasing an additional 752 shares during the quarter. KBC Group NV’s holdings in Kymera Therapeutics were worth $87,000 at the end of the […]
KBC Group NV boosted its position in Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 53.8% during the 4th quarter, HoldingsChannel.com reports. The firm owned 2,151 shares of the company’s stock after purchasing an additional 752 shares during the quarter. KBC Group NV’s holdings in Kymera Therapeutics were worth $87,000 at the end of the […]
